ATE547523T1 - Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden - Google Patents
Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leidenInfo
- Publication number
- ATE547523T1 ATE547523T1 AT07849615T AT07849615T ATE547523T1 AT E547523 T1 ATE547523 T1 AT E547523T1 AT 07849615 T AT07849615 T AT 07849615T AT 07849615 T AT07849615 T AT 07849615T AT E547523 T1 ATE547523 T1 AT E547523T1
- Authority
- AT
- Austria
- Prior art keywords
- pregnancy
- diagnosis
- treatment
- conditions associated
- medical conditions
- Prior art date
Links
- 108091008605 VEGF receptors Proteins 0.000 title 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 230000035935 pregnancy Effects 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 239000002157 polynucleotide Substances 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87582206P | 2006-12-20 | 2006-12-20 | |
| PCT/IL2007/001589 WO2008075363A1 (en) | 2006-12-20 | 2007-12-20 | Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE547523T1 true ATE547523T1 (de) | 2012-03-15 |
Family
ID=39271517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07849615T ATE547523T1 (de) | 2006-12-20 | 2007-12-20 | Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20100136012A1 (enExample) |
| EP (1) | EP2099913B1 (enExample) |
| JP (1) | JP2010512781A (enExample) |
| AT (1) | ATE547523T1 (enExample) |
| CA (1) | CA2673222A1 (enExample) |
| WO (1) | WO2008075363A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2099913B1 (en) | 2006-12-20 | 2012-02-29 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| JPWO2010106997A1 (ja) * | 2009-03-19 | 2012-09-20 | 株式会社カネカ | 核酸の検出方法及びキット、デバイス |
| US20130164270A1 (en) | 2009-07-29 | 2013-06-27 | Yissum Research Developement Company of the Hebrew University of Jerusalem Ltd. | Polynucleotides and constructs encoding sflt1-14 and method for efficient propagation and expression thereof |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| RU2670747C1 (ru) * | 2017-10-19 | 2018-10-25 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Способ определения показаний для срочного родоразрешения при преэклампсии |
| FR3081707A1 (fr) * | 2018-05-30 | 2019-12-06 | Universite De Rouen Normandie | Traitement des troubles neurologiques causes par l'alcoolisation foetale |
| WO2020171777A1 (en) * | 2019-02-18 | 2020-08-27 | Agency For Science, Technology And Research | A membrane-bound fit-1 decoy and uses thereof |
| EP4070113A4 (en) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6710174B2 (en) * | 2001-09-13 | 2004-03-23 | Isis Pharmaceuticals, Inc. | Antisense inhibition of vascular endothelial growth factor receptor-1 expression |
| AU2001238347A1 (en) * | 2000-02-28 | 2001-09-12 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US20040216828A1 (en) * | 2001-08-17 | 2004-11-04 | Ortega Albert E. | Nonwoven fabrics with two or more filament cross sections |
| KR101215701B1 (ko) * | 2002-07-19 | 2012-12-26 | 베스 이스라엘 데코니스 메디칼 센터 | 자간전증 또는 자간의 진단 및 치료 방법 |
| US7939634B2 (en) * | 2004-01-27 | 2011-05-10 | Compugen Ltd. | Polynucleotides encoding polypeptides and methods using same |
| US20080305493A1 (en) | 2004-03-08 | 2008-12-11 | Avalon Pharmaceuticals | Determining Cancer-Linked Genes and Therapeutic Targets Using Molecular Cytogenetic Methods |
| JP5009811B2 (ja) * | 2004-12-21 | 2012-08-22 | イェール ユニバーシティ | 子癇前症の検出 |
| IL172297A (en) * | 2005-10-03 | 2016-03-31 | Compugen Ltd | Soluble vegfr-1 variants for the diagnosis of preeclampsia |
| EP2099913B1 (en) | 2006-12-20 | 2012-02-29 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
-
2007
- 2007-12-20 EP EP07849615A patent/EP2099913B1/en not_active Not-in-force
- 2007-12-20 WO PCT/IL2007/001589 patent/WO2008075363A1/en not_active Ceased
- 2007-12-20 AT AT07849615T patent/ATE547523T1/de active
- 2007-12-20 JP JP2009542395A patent/JP2010512781A/ja active Pending
- 2007-12-20 CA CA002673222A patent/CA2673222A1/en not_active Abandoned
- 2007-12-20 US US12/448,404 patent/US20100136012A1/en not_active Abandoned
-
2012
- 2012-11-27 US US13/685,892 patent/US20130084583A1/en not_active Abandoned
-
2014
- 2014-06-15 US US14/304,948 patent/US9797911B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US9797911B2 (en) | 2017-10-24 |
| US20130084583A1 (en) | 2013-04-04 |
| EP2099913A1 (en) | 2009-09-16 |
| US20100136012A1 (en) | 2010-06-03 |
| WO2008075363A1 (en) | 2008-06-26 |
| EP2099913B1 (en) | 2012-02-29 |
| CA2673222A1 (en) | 2008-06-26 |
| JP2010512781A (ja) | 2010-04-30 |
| US20140295454A1 (en) | 2014-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE547523T1 (de) | Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden | |
| AR064642A1 (es) | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi | |
| DE69922261D1 (de) | Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten | |
| RU2011108943A (ru) | Профилактика, лечение и диагностика инфекции, вызванной бактериями p.gingivalis | |
| EP2730659A3 (en) | Treatment and Prophylaxis of Amyloidosis | |
| EP1498424A3 (de) | Humane Nukleinsäuresequenzen aus Bronchialkarzinomen | |
| PE20071055A1 (es) | Anticuerpos anti mn | |
| EP2292648A3 (en) | Small Streptococcus pyogenes antigens and their use | |
| MX345316B (es) | Métodos y composiciones para diagnóstico y tratamiento del cáncer. | |
| CY1108568T1 (el) | Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α | |
| MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. | |
| WO2008016385A3 (en) | Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof | |
| NO20081453L (no) | Sammensetninger og fremgangsmater for diagnostisering og behandling av inflammasjon | |
| EP2530090A3 (en) | Anti-IL-13R alpha 1 antibodies and their uses thereof | |
| EA200700951A1 (ru) | БЕЛКИ, СОДЕРЖАЩИЕ ДОМЕНЫ vWFA И/ИЛИ ANT_IG | |
| RU2010139903A (ru) | Оптимизированные фрагменты адгезина и соответствующие наночастицы | |
| ATE334145T1 (de) | Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen | |
| JP2011509080A5 (enExample) | ||
| DE602006004966D1 (de) | Intrinsic-faktor vom schwein | |
| ATE466023T1 (de) | Mannose-spezifische adhesinen und deren vervendung | |
| JP2020505060A (ja) | 腫瘍壊死因子αの高親和性ペプチド及びその適用 | |
| ATE369426T1 (de) | Nukleinsäure- und aminosäuresequenzen von durch hämoglobin induzierbaren genen aus candida albicans und die verwendung dieser sequenzen in reagenzien zur diagnose von disseminierten candida albicans infektionen | |
| ATE512983T1 (de) | Rezeptor für das tgr3-like protein | |
| WO2007049065A3 (en) | Vwfa, collagen and kunitz domain containing protein | |
| JP2016175891A5 (enExample) |